跳至主要内容
临床试验/CTRI/2024/04/066362
CTRI/2024/04/066362尚未招募4 期

Impact of multipronged interventions targeting healthcare professionals in reducing surgical site infections and identifying the challenges in adoption of these interventions- an implementation research

Indian Council of Medical Research7 个研究点 分布在 1 个国家目标入组 6,860 人开始时间: 2024年6月1日最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
6,860
试验地点
7
主要终点
The rate of surgical site infection till 30 days after surgery (90 days if implant) using CDC definition of SSI in pre-intervention versus post-intervention phase for clean, clean-contaminated and contaminated surgeries

研究概览

简要总结

The study is "Impact of multipronged interventions targeting healthcare professionals in reducing surgical site infections and identifying the challenges in adoption of these interventions."

Multicentric study (7 sites in India) with mixed method design. 

Phase-I will involve formative research and practice analysis. Phase-II will involve co-development of the multipronged interventions. Phase-III will involve deployment of the multipronged interventions and process evaluation. Phase-IV will involve impact assessment and dissemination of results.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
1.00 Year(s) 至 85.00 Year(s)(—)
性别
All

入选标准

  • Surgical patients undergoing elective or emergency procedure (open or laparoscopic) under general surgery, neurosurgery, orthopedics, pediatric surgery, plastic surgery, urology.

排除标准

  • 未提供

结局指标

主要结局

The rate of surgical site infection till 30 days after surgery (90 days if implant) using CDC definition of SSI in pre-intervention versus post-intervention phase for clean, clean-contaminated and contaminated surgeries

时间窗: The rate of surgical site infection till 30 days after surgery (90 days if implant) using CDC definition of SSI in pre-intervention versus post-intervention phase for clean, clean-contaminated and contaminated surgeries

次要结局

  • The number of ICU admissions averted and number of readmissions averted in clean, clean-contaminated and contaminated surgeries by adoption of multipronged interventions(30 days after surgery)
  • The length of index hospital admission in pre-intervention and intervention phase for clean, clean-contaminated and contaminated surgeries.(post-operatively)
  • The antimicrobial consumption indicators (Days of therapy) in the pre-intervention and intervention phase for clean, clean-contaminated and contaminated surgeries(peri-operative period)
  • The percentage of patients receiving single dose of antimicrobial prophylaxis in the pre-intervention and intervention phase for clean, clean-contaminated and contaminated surgeries(Peri-operative period)
  • The percentage of patients receiving prolonged antimicrobial prophylaxis in the pre-intervention and intervention phase for clean, clean-contaminated and contaminated surgeries(Peri-operative period)
  • The percentage of irrational combinations of drugs (double gram positive, double gram negative or double anaerobic coverage) for surgical antimicrobial prophylaxis in the pre-intervention and intervention phase for clean, clean-contaminated and contaminated surgeries(Peri-operative period)
  • The number of deaths prevented in clean, clean-contaminated and contaminated surgeries by adoption of multipronged interventions(30 days after surgery)
  • Acceptance of these multipronged interventions and challenges in their implementation by healthcare professionals(Peri-operative)

研究者

申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr Rachna Rohilla

All India Institute of Medical Sciences, Bathinda

研究点 (7)

Loading locations...

相似试验